0

Digital Diabetes Management Market by Type and Geography - Forecast and Analysis 2022-2026

  • Published: Dec 2021
  • Pages: 120
  • SKU: IRTNTR71704
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The digital diabetes management market share is expected to increase by USD 12.45 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 21.15%.

This digital diabetes management market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers digital diabetes management market segmentation by type (wearable devices and hand-held devices) and geography (North America, Europe, APAC, South America, and MEA). The digital diabetes management market report also offers information on several market vendors, including Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Co., DarioHealth Corp., Dassault Systemes SE, decide Clinical Software GmbH, Dexcom Inc., Intel Corp., PHC Holdings Corp., and WaveForm Technologies Inc among others.

What will the Digital Diabetes Management Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Digital Diabetes Management Market Size for the Forecast Period and Other Important Statistics

 

Digital Diabetes Management Market: Key Drivers and Challenges

The rising global burden of diabetes is notably driving the digital diabetes management market growth, although factors such as stringent regulatory framework may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the digital diabetes management industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Digital Diabetes Management Market Driver

The global prevalence of the disease is increasing rapidly. It is projected that the number of diabetic patients will be doubled in the next 25 years. The growing incidence of type 1 and type 2 diabetes will significantly increase healthcare costs. The factors contributing to the increase in the diabetic population include obesity, smoking, sedentary lifestyle, and growing urbanization. The incidence of diabetes is more in the case of the older population. Furthermore, the diabetic prevalence is high in European countries. Countries with a higher population base, such as China and India, are likely to have a higher incidence of diabetes due to increased obesity and urbanization factors. Thus, the increasing incidence of diabetes is likely to increase the adoption of digital diabetes management systems, which is expected to drive market growth. 

Key Digital Diabetes Management Market Challenge

Medical devices regulations must be improved to ensure high-quality, efficient, and safe technologies reach individuals. The growing number and modernization of medical devices have introduced new regulatory challenges. Vendors offering advanced digital diabetes management devices need to comply with the stringent regulatory scenario before its release into the market. The US FDA classified the diabetes care management devices such as insulin pumps, infusion sets, and insulin bolus under the Class II category. Failing to adhere to the US FDA regulations or causing complications would lead to the product's recall. A product recall will significantly affect the company's brand name. Thus, the vendors focusing on adopting innovative technologies and designing novel products should undergo stringent postmarket approvals before its launch. Therefore, the stringent regulatory scenario could potentially hamper the digital diabetes management market. 

This digital diabetes management market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major Digital Diabetes Management Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton Dickinson and Co.
  • DarioHealth Corp.
  • Dassault Systemes SE
  • decide Clinical Software GmbH
  • Dexcom Inc.
  • Intel Corp.
  • PHC Holdings Corp.
  • WaveForm Technologies Inc

 

This statistical study of the digital diabetes management market encompasses successful business strategies deployed by the key vendors. The digital diabetes management market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The digital diabetes management market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Digital Diabetes Management Market?

For more insights on the market share of various regions Request for a FREE sample now!

48% of the market’s growth will originate from North America during the forecast period. The US is a key market for digital diabetes management in North America. Market growth in North America will be faster than the growth of the market in other regions.

The increase in technological advances and a high incidence of type 1 and type 2 diabetes will facilitate the digital diabetes management market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Type Segments in the Digital Diabetes Management Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The digital diabetes management market share growth by the wearable devices segment will be significant during the forecast period. The increasing awareness among individuals about glucose monitoring and the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery are the major factors driving the growth of the wearable devices segment. Moreover, growth in the number of regulatory approvals for CGM systems and the development of advanced wearable products such as closed-loop pump systems and smart insulin patches will further enhance the growth of the wearable devices segment of the global digital diabetes management market.

This report provides an accurate prediction of the contribution of all the segments to the growth of the digital diabetes management market size and actionable market insights on post COVID-19 impact on each segment.

 

Digital Diabetes Management Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 21.15%

Market growth 2022-2026

$ 12.45 billion

Market structure

Fragmented

YoY growth (%)

20.33

Regional analysis

North America, Europe, APAC, South America, and MEA

Performing market contribution

North America at 48%

Key consumer countries

US, Germany, France, China, and UK

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Co., DarioHealth Corp., Dassault Systemes SE, decide Clinical Software GmbH, Dexcom Inc., Intel Corp., PHC Holdings Corp., and WaveForm Technologies Inc

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Digital Diabetes Management Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive digital diabetes management market growth during the next five years
  • Precise estimation of the digital diabetes management market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the digital diabetes management industry across North America, Europe, APAC, South America, and MEA
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of digital diabetes management market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2021
    • Market outlook: Forecast for 2021 - 2026

    Five Forces Analysis

    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Type

    • Market segments
    • Comparison by Type
    • Wearable devices - Market size and forecast 2021-2026
    • Hand-held devices - Market size and forecast 2021-2026
    • Market opportunity by Type

    Customer landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • North America - Market size and forecast 2021-2026
      • Europe - Market size and forecast 2021-2026
      • APAC - Market size and forecast 2021-2026
      • South America - Market size and forecast 2021-2026
      • MEA - Market size and forecast 2021-2026
      • Key leading countries
      • Market opportunity by geography
      • Market drivers
      • Market challenges
      • Market trends

      Vendor Landscape

      • Vendor landscape
      • Landscape disruption

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • Abbott Laboratories
      • B. Braun Melsungen AG
      • Becton Dickinson and Co.
      • DarioHealth Corp.
      • Dassault Systemes SE
      • decide Clinical Software GmbH
      • Dexcom Inc.
      • Intel Corp.
      • PHC Holdings Corp.
      • WaveForm Technologies Inc

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Framework

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      TechnavioINFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases
      Technavio

      TechnavioDATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts
      Technavio

      TechnavioREPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape
      Interested in this report?
      Get your FREE sample now!
      The digital diabetes management market growth will increase by $12451.03 million during 2021-2026.
      The digital diabetes management market is expected to grow at a CAGR of 21.15% during 2021-2026.
      Technavio has segmented the digital diabetes management market by type (Wearable devices and Hand-held devices) and geographic (North America, Europe, APAC, South America, and MEA).
      Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Co., DarioHealth Corp., Dassault Systemes SE, decide Clinical Software GmbH, Dexcom Inc., Intel Corp., PHC Holdings Corp., WaveForm Technologies Inc are a few of the key vendors in the digital diabetes management market.
      North America will register the highest growth rate of 47.92% among the other regions. Therefore, the digital diabetes management market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
      The key factors driving the digital diabetes management market growth are:
      • Rising global burden of diabetes
      The digital diabetes management market vendors should focus on grabbing business opportunities from the wearable devices segment as it accounted for the largest market share in the base year.
      Safe and Secure SSL Encrypted
      Technavio

      Single User:

      2500 USD

      Technavio Get the report (PDF) sent to your email within minutes.

      Subscribe & Save

      Get lifetime access to our
      Technavio Insights

      Want to customize this report?

      This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

      We offer $1000 worth of FREE customization at the time of purchase
      Technavio
      Enquire Before Buying
      1. Home
      2. Health Care
      3. Published Report
      17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>